These results open up new perspectives, particularly for patients with kidney cancer or urothelial carcinoma.
These results open up new perspectives, particularly for patients with kidney cancer or urothelial carcinoma.
In this study, we demonstrate that:
- GFR measured by CT is more accurate than GFR estimated from creatinine, cystatin C, or both (eGFRcr-cys).
In this study, we demonstrate that:
- GFR measured by CT is more accurate than GFR estimated from creatinine, cystatin C, or both (eGFRcr-cys).
The originality of this study also lies in our attempt to identify the determinants of such a low ratio by including body composition data in the analyses.
The originality of this study also lies in our attempt to identify the determinants of such a low ratio by including body composition data in the analyses.
A low eGFRcys/eGFRcr ratio is increasingly recognized as a risk factor for morbidity and mortality, including CV events.
However, there was little or no data available on kidney transplantation.
A low eGFRcys/eGFRcr ratio is increasingly recognized as a risk factor for morbidity and mortality, including CV events.
However, there was little or no data available on kidney transplantation.
It is therefore likely that myosteatosis is associated with frailty, in addition to cardiovascular risk.
It is therefore likely that myosteatosis is associated with frailty, in addition to cardiovascular risk.